GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EOM Pharmaceutical Holdings Inc (OTCPK:IMUC) » Definitions » Cyclically Adjusted PB Ratio

EOM Pharmaceutical Holdings (EOM Pharmaceutical Holdings) Cyclically Adjusted PB Ratio : (As of May. 16, 2024)


View and export this data going back to 2006. Start your Free Trial

What is EOM Pharmaceutical Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


EOM Pharmaceutical Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for EOM Pharmaceutical Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EOM Pharmaceutical Holdings Cyclically Adjusted PB Ratio Chart

EOM Pharmaceutical Holdings Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

EOM Pharmaceutical Holdings Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of EOM Pharmaceutical Holdings's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, EOM Pharmaceutical Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EOM Pharmaceutical Holdings's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EOM Pharmaceutical Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where EOM Pharmaceutical Holdings's Cyclically Adjusted PB Ratio falls into.



EOM Pharmaceutical Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

EOM Pharmaceutical Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2018 is calculated as:

For example, EOM Pharmaceutical Holdings's adjusted Book Value per Share data for the three months ended in Jun. 2018 was:

Adj_Book=Book Value per Share/CPI of Jun. 2018 (Change)*Current CPI (Jun. 2018)
=0.818/106.3168*106.3168
=0.818

Current CPI (Jun. 2018) = 106.3168.

EOM Pharmaceutical Holdings Quarterly Data

Book Value per Share CPI Adj_Book
200809 110.943 92.307 127.781
200812 92.715 88.697 111.132
200903 76.254 89.744 90.335
200906 58.313 91.003 68.126
200909 49.864 91.120 58.180
200912 29.513 91.111 34.438
201003 44.725 91.821 51.786
201006 88.122 91.962 101.878
201009 69.384 92.162 80.041
201012 42.067 92.474 48.364
201103 68.912 94.283 77.707
201106 54.457 95.235 60.794
201109 62.866 95.727 69.821
201112 45.184 95.213 50.453
201203 66.524 96.783 73.077
201206 23.201 96.819 25.477
201209 29.442 97.633 32.061
201212 179.169 96.871 196.639
201303 142.654 98.209 154.430
201306 170.832 98.518 184.356
201309 177.882 98.790 191.435
201312 184.026 98.326 198.982
201403 163.269 99.695 174.114
201406 163.772 100.560 173.148
201409 153.962 100.428 162.990
201412 146.481 99.070 157.196
201503 143.454 99.621 153.096
201506 130.469 100.684 137.768
201509 116.441 100.392 123.314
201512 96.200 99.792 102.490
201603 72.083 100.470 76.278
201606 50.884 101.688 53.200
201609 33.763 101.861 35.240
201612 17.801 101.863 18.579
201703 1.389 102.862 1.436
201706 -8.270 103.349 -8.507
201709 -0.220 104.136 -0.225
201712 1.109 104.011 1.134
201803 0.876 105.290 0.885
201806 0.818 106.317 0.818

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


EOM Pharmaceutical Holdings  (OTCPK:IMUC) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


EOM Pharmaceutical Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of EOM Pharmaceutical Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EOM Pharmaceutical Holdings (EOM Pharmaceutical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
136 Summit Avenue, Suite 100, Montvale, NJ, USA, 07645
EOM Pharmaceutical Holdings Inc is focused on developing novel immunomodulatory and retinal disease drug agents to address a range of inflammatory, viral, retinal, and other diseases. Its product candidate includes dual-acting broad-spectrum immunomodulator EOM613, which has the potential to treat cancer cachexia and rheumatoid arthritis, and its advanced formulation of EOM147 is being studied to treat serious retinal diseases without the need for intraocular injection.
Executives
Andrew Gengos director 21900 BURBANK BOULEVARD, 3RD FLOOR, WOODLAND HILLS CA 91367
Gary Titus director, officer: Chairman and Secretary SCICLONE PHARMACEUTICALS, INC., 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404-2125
Anthony Gregg Lapointe director PO BOX 83216, GAITHERSBURG MD 20883-3216
Mark A Schlossberg director C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544
Rahul Singhvi director 246 HOLLY DRIVE, CHALFONT PA 18914
Helen Susan Kim director 3832 BAY CENTER PLACE, HAYWARD CA 94545
Richard Chin director C/O OXIGENE, INC., 230 THIRD AVENUE, WALTHAM MA 02451
Richard Cowell director 7840 VIRGINIA OAK DRIVE, GAINSVILLE VA 20155
James G. Bender officer: VP, Product Development & Mfg. 112 WEST 34TH STREET, 17TH FLOOR, NEW YORK NY 10120
Manish Singh director, officer: President & CEO 21900 BURBANK BOULEVARD, 3RD FLOOR, WOODLAND HILLS CA 91367
Jacqueline Brandwynne director 649 STONE CANYON ROAD, LOS ANGELES CA 90077